Cargando…
Local Injection for Treating Mood Disorders (LIFT-MOOD): A Pilot Feasibility RCT of Stellate Ganglion Block for Treatment-Resistant Depression
BACKGROUND: With nearly one-third of patients with major depressive disorder being resistant to available antidepressants, there is a need to develop new treatments for this population. Stellate ganglion block (SGB) is a procedure used to block sympathetic input to the central autonomic system; it h...
Autores principales: | Sussman, David, Tassone, Vanessa K, Gholamali Nezhad, Fatemeh, Wu, Michelle, Adamsahib, Fathima, Mattina, Gabriella F, Pazmino-Canizares, Janneth, Demchenko, Ilya, Jung, Hyejung, Lou, Wendy, Ladha, Karim S, Bhat, Venkat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989395/ https://www.ncbi.nlm.nih.gov/pubmed/36895443 http://dx.doi.org/10.1177/24705470231160315 |
Ejemplares similares
-
Stellate Ganglion Block for Psychiatric Disorders: A Systematic Review of the Clinical Research Landscape
por: Kerzner, Jaimie, et al.
Publicado: (2021) -
Efficacy of ketamine for comorbid depression and acute or chronic pain: A systematic review
por: Balachandran, Aksharra, et al.
Publicado: (2022) -
Virtual Reality Cognitive Remediation for Mood disorders: RCT pilot study
por: Lipskaya-Velikovsky, L., et al.
Publicado: (2022) -
Prospective preference assessment for the Comparison of Analgesic Regimen Effectiveness and Safety in Surgery (CARES) trial
por: Hyung, Brian, et al.
Publicado: (2022) -
IMPROVING MOOD THROUGH PHYSICAL ACTIVITY FOR CARERS AND CARE RECIPIENTS TRIAL (IMPACCT): RESULTS OF A RCT
por: Dow, Briony, et al.
Publicado: (2019)